TherapeuticsMD slumps after 1-for-50 reverse stock split

TherapeuticsMD

09/05/2022 15:47

** Shares of women-focused therapy maker  TXMD.O  fall 27.7%
to $5.54 after stock begins trading on split-adjusted basis on
Monday
    ** Stock the top loser on Nasdaq biotech index  .NBI  
    ** Co said in April its board had approved a 1-for-50
reverse stock to mainly regain compliance with Nasdaq on its
minimum bid price requirement; shares closed at 15 cents on
Friday
    ** Shares are down ~70% this year 

 (Reporting by Manas Mishra in Bengaluru)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manaswrites15))